Laurus Labs

625.40

-20.10 (-3.11%) tick

NSE

Buy Sell

NSE BSE

Last updated on 25 Apr 2025 09:43 AM

Open Demat account

Returns

-2.25%

Loading chart...

Fundamentals

Large Cap

Financial - Banking

Market Cap (Cr)

34897.72

Earning Per Share

4.15

Dividend Yield

0.2%

P/E Ratio

94.40

P/B Ratio

8.17

Debt to Equity

0.46

Performance

min-value

max-value

Open

56,601.30

52-wk High

75,250.00

High

56,601.30

52-wk Low

75,250.00

Low

56,601.30

Band

75,250.00

Lower Circuit

56,601.30

Upper Circuit

75,250.00

Volume

56,601.30

VWAP

75,250.00

52 Week Performance

min-value

max-value

5.34% down side

up side5.34%

About the company

Laurus Labs is a science-led, fully integrated pharmaceutical and biotechnology manufacturing company with a leadership position in generic active pharmaceutical ingredients (APIs) in selected high-growth therapeutic areas of anti-retrovirals (ARVs), Hepatitis C and Oncology. The company also manufactures APIs in oncology and other therapeutic areas, such as anti-asthma, ophthalmology, antidiabetics, cardiovascular, proton pump inhibitors (PPIs) amongst others. The company currently operates 4 manufacturing facilities in Visakhapatnam, Andhra Pradesh. Three of these facilities manufacture APIs and ingredients, while the fourth facility produces Finished Dosage Formulations (FDFs) and one API. The company's strategic and early investments in R&D and manufacturing infrastructure has enabled it to become one of the leading suppliers of APIs in the ARV therapeutic area to multi-national pharmaceutical formulation companies which cater to the large and fast-growing 'donor-funded access-to-medicines markets' of Sub-Saharan Africa, South-East Asia and Latin America.

Similar Companies

Suven Pharmaceuticals

1178.5 -26.30 (-0.02%) tick

1Yr Returns

+86.27%

Piramal Pharma Limited

216.59 -3.28 (-0.01%) tick

1Yr Returns

+54.89%

J.B.Chemicals & Pharma

1581.5 -27.60 (-0.02%) tick

1Yr Returns

-13.61%

Wockhardt

1430 -35.20 (-0.02%) tick

1Yr Returns

+156.75%

Emcure pharmaceuticals

1054.8 -18.40 (-0.02%) tick

1Yr Returns

-21.03%